Feasibility of focal treatment of localized prostate cancer with MRI / TRUS image fusion using the Focal One - PRO FOCUS

niversitätsklinik für Urologie und Kinderurologie0 个研究点目标入组 60 人开始时间: 2016年4月11日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Life expectancy> 10 years, PSA <= 15 ng / ml, clinically localized prostate cancer, the number of infested punching <= 30% of the extracted stamping cylinder, Gleason score <= 3 + 4 = 7, normal anal and rectal anatomy, maximum 2 in mpMRT visible lesions with PI-RADS score 4/5, rejection of also featured standard therapies, at least a visible lesion in mpMRT with a PI-RADS score 4/5, Accordance suspect mpMRT-areas with areas of positive punching

•not limited clinical tumor stage, evidence of lymph node or distant metastases in the imaging, more than 2 visible MRI lesions with PI-RADS 4/5, no suspicious MRI lesion (PI RAS 4/5) with positive punch in the same sector, existing Urethralstenosen, unresolved coagulopathy, untreated urogenital infections, latex allergies, contraindications to MRI (pacemaker, metal prostheses o. ä.), participating in a treatment study for prostate within the last 30 days, missing capacity to consent, ongoing antihormonal therapy, TURP in the last 6 months

发起方

niversitätsklinik für Urologie und Kinderurologie